Literature DB >> 19728762

Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.

L Kovarova1, I Buresova, T Buchler, R Suska, L Pour, L Zahradova, M Penka, R Hajek.   

Abstract

Flow cytometry is a useful tool for the analysis of plasma cells in monoclonal gammopathies. The aim of this study was to find possibilities and limits of multicolour flow cytometry in diagnostics of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) and to identify parameters that could be used to differentiate between these two disorders. Surface markers CD38 and CD138 were used for identification of plasma cells, CD19 and CD56 further distinguished normal and abnormal plasma cells, respectively. The percentage of circulating plasma cells in peripheral blood was lower in MGUS patients then in MM (p<0,001) In bone marrow, the percentage of residual polyclonal CD19 plasma cell was higher (p<0,001) and the percentage of malignant monoclonal CD56 plasma cell was lower (p<0,001) in MGUS than in MM. In conclusion, flow cytometry is relatively quick and effective method for analysis of plasma cells thus immunophenotyping can significantly contribute to the differential diagnosis of plasma cell proliferations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728762     DOI: 10.4149/neo_2009_06_526

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  5 in total

1.  Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.

Authors:  Minjie Gao; Hua Bai; Yogesh Jethava; Yujie Wu; Yuqi Zhu; Ye Yang; Jiliang Xia; Huojun Cao; Reinaldo Franqui-Machin; Kalyan Nadiminti; Gregory S Thomas; Mohamed E Salama; Peter Altevogt; Gail Bishop; Michael Tomasson; Siegfried Janz; Jumei Shi; Lijuan Chen; Ivana Frech; Guido Tricot; Fenghuang Zhan
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

2.  Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting.

Authors:  Jana Cumova; L Kovarova; A Potacova; I Buresova; F Kryukov; M Penka; J Michalek; R Hajek
Journal:  Int J Hematol       Date:  2010-08-07       Impact factor: 2.490

3.  Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells.

Authors:  Tae-Dong Jeong; Chan-Jeoung Park; Hyoeun Shim; Seongsoo Jang; Hyun-Sook Chi; Dok Hyun Yoon; Dae-Young Kim; Jung-Hee Lee; Je-Hwan Lee; Cheolwon Suh; Kyoo Hyung Lee
Journal:  Korean J Hematol       Date:  2012-12-24

4.  Phenotypic consensus markers for plasma cell myeloma.

Authors:  Mina Hur
Journal:  Korean J Hematol       Date:  2012-12-24

Review 5.  Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma.

Authors:  Sarah M Tete; Marc Bijl; Surinder S Sahota; Nicolaas A Bos
Journal:  Front Immunol       Date:  2014-06-03       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.